Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Mar;35(3):302–304.

The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.

J Sahai 1, D P Healy 1, J Stotka 1, R E Polk 1
PMCID: PMC1381579  PMID: 8471407

Abstract

Six healthy male volunteers participated in a two-period, two-treatment study to determine the effect of chronic calcium carbonate administration on ciprofloxacin bioavailability. There was a mean reduction of 40% in Cmax and 43% in AUC when calcium carbonate was administered with ciprofloxacin, compared with ciprofloxacin alone (P < 0.05). There were no changes in either half-life or tmax. It is therefore recommended that patients being treated with ciprofloxacin for serious infections refrain from ingesting calcium supplements. If this is not possible, administration of ciprofloxacin 2 h before ingestion of the supplement is suggested.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fleming L. W., Moreland T. A., Stewart W. K., Scott A. C. Ciprofloxacin and antacids. Lancet. 1986 Aug 2;2(8501):294–294. doi: 10.1016/s0140-6736(86)92120-3. [DOI] [PubMed] [Google Scholar]
  2. Frost R. W., Carlson J. D., Dietz A. J., Jr, Heyd A., Lettieri J. T. Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast. J Clin Pharmacol. 1989 Oct;29(10):953–955. doi: 10.1002/j.1552-4604.1989.tb03260.x. [DOI] [PubMed] [Google Scholar]
  3. Frost R. W., Lasseter K. C., Noe A. J., Shamblen E. C., Lettieri J. T. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother. 1992 Apr;36(4):830–832. doi: 10.1128/aac.36.4.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Höffken G., Borner K., Glatzel P. D., Koeppe P., Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol. 1985 Jun;4(3):345–345. doi: 10.1007/BF02013667. [DOI] [PubMed] [Google Scholar]
  5. Lomaestro B. M., Bailie G. R. Effect of staggered dose of calcium on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother. 1991 May;35(5):1004–1007. doi: 10.1128/aac.35.5.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Neuvonen P. J., Kivistö K. T., Lehto P. Interference of dairy products with the absorption of ciprofloxacin. Clin Pharmacol Ther. 1991 Nov;50(5 Pt 1):498–502. doi: 10.1038/clpt.1991.174. [DOI] [PubMed] [Google Scholar]
  7. Nix D. E., De Vito J. M., Schentag J. J. Liquid-chromatographic determination of ciprofloxacin in serum and urine. Clin Chem. 1985 May;31(5):684–686. [PubMed] [Google Scholar]
  8. Polk R. E. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med. 1989 Nov 30;87(5A):76S–81S. doi: 10.1016/0002-9343(89)90028-4. [DOI] [PubMed] [Google Scholar]
  9. Polk R. E., Healy D. P., Sahai J., Drwal L., Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989 Nov;33(11):1841–1844. doi: 10.1128/aac.33.11.1841. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES